MX341015B - Forma de dosificacion de liberacion extendida. - Google Patents
Forma de dosificacion de liberacion extendida.Info
- Publication number
- MX341015B MX341015B MX2009008197A MX2009008197A MX341015B MX 341015 B MX341015 B MX 341015B MX 2009008197 A MX2009008197 A MX 2009008197A MX 2009008197 A MX2009008197 A MX 2009008197A MX 341015 B MX341015 B MX 341015B
- Authority
- MX
- Mexico
- Prior art keywords
- bead
- extended
- release dosage
- dosage form
- inner core
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/501—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5015—Organic compounds, e.g. fats, sugars
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
- A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
- A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
- A61K9/5047—Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5084—Mixtures of one or more drugs in different galenical forms, at least one of which being granules, microcapsules or (coated) microparticles according to A61K9/16 or A61K9/50, e.g. for obtaining a specific release pattern or for combining different drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Inorganic Chemistry (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Cardiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Heart & Thoracic Surgery (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Se proporcionan formulaciones farmacéuticas que comprenden partículas de liberación sostenida teniendo cada una un lecho de núcleo interno que comprende un ingrediente farmacéutico activo un recubrimiento intermedio que rodea sustancialmente el lecho de núcleo interno, y un recubrimiento externo que rodea sustancialmente el recubrimiento intermedio que comprende un polímero independiente de pH. También se proporciona una formulación farmacéutica que comprende dos poblaciones de lecho, en donde cada una de la primera y segunda población de lecho tiene un perfil de liberación de fármaco diferente. También se proporciona un método para preparar una composición de dosificación de liberación extendida que comprende una o más poblaciones de lecho.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US11/701,178 US20080187579A1 (en) | 2007-02-01 | 2007-02-01 | Extended-release dosage form |
PCT/US2008/000926 WO2008094440A1 (en) | 2007-02-01 | 2008-01-24 | Extended-release dosage form |
Publications (2)
Publication Number | Publication Date |
---|---|
MX2009008197A MX2009008197A (es) | 2009-10-28 |
MX341015B true MX341015B (es) | 2016-08-04 |
Family
ID=39496215
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2009008197A MX341015B (es) | 2007-02-01 | 2008-01-24 | Forma de dosificacion de liberacion extendida. |
Country Status (11)
Country | Link |
---|---|
US (3) | US20080187579A1 (es) |
EP (1) | EP2114382A1 (es) |
JP (2) | JP5868571B2 (es) |
KR (1) | KR20090109117A (es) |
CN (1) | CN101646422A (es) |
AU (1) | AU2008211318B2 (es) |
BR (1) | BRPI0807001A2 (es) |
CA (1) | CA2676650C (es) |
MX (1) | MX341015B (es) |
NZ (1) | NZ578656A (es) |
WO (1) | WO2008094440A1 (es) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8445018B2 (en) | 2006-09-15 | 2013-05-21 | Cima Labs Inc. | Abuse resistant drug formulation |
MX2012003082A (es) * | 2009-09-17 | 2012-04-19 | Cadila Healthcare Ltd | Composiciones farmaceuticas para reducir la absorcion rapida de la dosis inducida por el alcohol. |
PL2872121T3 (pl) | 2012-07-12 | 2019-02-28 | SpecGx LLC | Kompozycje farmaceutyczne o przedłużonym uwalnianiu, zniechęcające do nadużywania |
CN104587472B (zh) * | 2014-12-31 | 2017-12-15 | 广东国方医药科技有限公司 | 一种含纳米SiO2的包衣剂及其制备方法 |
US20170119680A1 (en) * | 2015-10-30 | 2017-05-04 | R.P. Scherer Technologies, Llc | Extended release film-coated capsules |
AU2017217464B2 (en) * | 2016-02-11 | 2022-11-10 | Biogen Ma Inc. | Pharmaceutical bead formulations comprising dimethyl fumarate |
US10406336B2 (en) | 2016-08-03 | 2019-09-10 | Neil S. Davey | Adjustable rate drug delivery implantable device |
CN114288273B (zh) * | 2022-02-11 | 2022-10-18 | 桂林华信制药有限公司 | 一种盐酸文拉法辛缓释胶囊及其生产工艺 |
Family Cites Families (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1561204A (en) * | 1977-06-01 | 1980-02-13 | Ici Ltd | Sustained release pharmaceutical composition |
US4587118A (en) * | 1981-07-15 | 1986-05-06 | Key Pharmaceuticals, Inc. | Dry sustained release theophylline oral formulation |
US4556678A (en) * | 1982-06-24 | 1985-12-03 | Key Pharmaceuticals, Inc. | Sustained release propranolol tablet |
PH18946A (en) * | 1983-04-21 | 1985-11-14 | Elan Corp Plc | Controlled absorption pharmaceutical composition |
EP0164669B1 (de) * | 1984-06-13 | 1991-01-23 | Röhm Gmbh | Verfahren zum Überziehen von Arzneiformen |
US4728512A (en) * | 1985-05-06 | 1988-03-01 | American Home Products Corporation | Formulations providing three distinct releases |
SE455836B (sv) * | 1985-10-11 | 1988-08-15 | Haessle Ab | Beredning med kontrollerad frisettning innehallande ett salt av metoprolol samt metod for framstellning av denna beredning |
US5026559A (en) * | 1989-04-03 | 1991-06-25 | Kinaform Technology, Inc. | Sustained-release pharmaceutical preparation |
US5133974A (en) * | 1989-05-05 | 1992-07-28 | Kv Pharmaceutical Company | Extended release pharmaceutical formulations |
US5683719A (en) * | 1990-11-22 | 1997-11-04 | British Technology Group Limited | Controlled release compositions |
US5260069A (en) * | 1992-11-27 | 1993-11-09 | Anda Sr Pharmaceuticals Inc. | Pulsatile particles drug delivery system |
US5376384A (en) * | 1992-12-23 | 1994-12-27 | Kinaform Technology, Inc. | Delayed, sustained-release pharmaceutical preparation |
DE19504832A1 (de) * | 1995-02-14 | 1996-08-22 | Basf Ag | Feste Wirkstoff-Zubereitungen |
IT1289160B1 (it) * | 1997-01-08 | 1998-09-29 | Jagotec Ag | Compressa farmaceutica completamente rivestita per il rilascio controllato di principi attivi che presentano problemi di |
WO2000018500A1 (de) * | 1998-09-24 | 2000-04-06 | Glatt Systemtechnik Dresden Gmbh | Einrichtung zur herstellung eines schüttfähigen produktes und verfahren zur anwendung der einrichtung |
US20030180352A1 (en) * | 1999-11-23 | 2003-09-25 | Patel Mahesh V. | Solid carriers for improved delivery of active ingredients in pharmaceutical compositions |
US6500454B1 (en) * | 2001-10-04 | 2002-12-31 | Eurand Pharmaceuticals Ltd. | Timed, sustained release systems for propranolol |
US9358214B2 (en) * | 2001-10-04 | 2016-06-07 | Adare Pharmaceuticals, Inc. | Timed, sustained release systems for propranolol |
US7401157B2 (en) * | 2002-07-30 | 2008-07-15 | Brocade Communications Systems, Inc. | Combining separate infiniband subnets into virtual subnets |
US6780003B2 (en) * | 2002-08-02 | 2004-08-24 | Mold-Masters Limited | Removable heater for a hot runner nozzle |
GB0222612D0 (en) * | 2002-09-30 | 2002-11-06 | Univ Gent | Controlled delivery system for bioactive substances |
US9107804B2 (en) * | 2002-12-10 | 2015-08-18 | Nortec Development Associates, Inc. | Method of preparing biologically active formulations |
US8367111B2 (en) * | 2002-12-31 | 2013-02-05 | Aptalis Pharmatech, Inc. | Extended release dosage forms of propranolol hydrochloride |
-
2007
- 2007-02-01 US US11/701,178 patent/US20080187579A1/en not_active Abandoned
-
2008
- 2008-01-24 AU AU2008211318A patent/AU2008211318B2/en not_active Ceased
- 2008-01-24 WO PCT/US2008/000926 patent/WO2008094440A1/en active Application Filing
- 2008-01-24 MX MX2009008197A patent/MX341015B/es active IP Right Grant
- 2008-01-24 BR BRPI0807001-6A2A patent/BRPI0807001A2/pt not_active Application Discontinuation
- 2008-01-24 NZ NZ578656A patent/NZ578656A/en not_active IP Right Cessation
- 2008-01-24 CN CN200880009949A patent/CN101646422A/zh active Pending
- 2008-01-24 CA CA2676650A patent/CA2676650C/en not_active Expired - Fee Related
- 2008-01-24 JP JP2009548269A patent/JP5868571B2/ja not_active Expired - Fee Related
- 2008-01-24 EP EP08724778A patent/EP2114382A1/en not_active Withdrawn
- 2008-01-24 KR KR1020097017971A patent/KR20090109117A/ko not_active Application Discontinuation
-
2010
- 2010-12-23 US US12/977,713 patent/US20110123613A1/en not_active Abandoned
-
2014
- 2014-05-30 JP JP2014111987A patent/JP5876896B2/ja not_active Expired - Fee Related
-
2016
- 2016-07-25 US US15/218,620 patent/US20170049724A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
JP2010518002A (ja) | 2010-05-27 |
AU2008211318B2 (en) | 2013-08-01 |
BRPI0807001A2 (pt) | 2014-04-15 |
CN101646422A (zh) | 2010-02-10 |
US20110123613A1 (en) | 2011-05-26 |
CA2676650C (en) | 2014-09-16 |
NZ578656A (en) | 2011-06-30 |
EP2114382A1 (en) | 2009-11-11 |
US20080187579A1 (en) | 2008-08-07 |
JP2014208655A (ja) | 2014-11-06 |
JP5876896B2 (ja) | 2016-03-02 |
US20170049724A1 (en) | 2017-02-23 |
WO2008094440A1 (en) | 2008-08-07 |
CA2676650A1 (en) | 2008-08-07 |
AU2008211318A1 (en) | 2008-08-07 |
JP5868571B2 (ja) | 2016-02-24 |
MX2009008197A (es) | 2009-10-28 |
KR20090109117A (ko) | 2009-10-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2009008197A (es) | Forma de dosificacion de liberacion extendida. | |
WO2008022932A3 (en) | Controlled release system and method for manufacturing the same | |
WO2007103557A3 (en) | Coating capsules with active pharmaceutical ingredients | |
WO2009117130A3 (en) | Extended release forumulation containing a wax | |
WO2008132712A3 (en) | Combination pharmaceutical compositions | |
MX2011006578A (es) | Formulaciones farmaceuticas de liberacion prolongada. | |
WO2007036952A3 (en) | Novel sustained release dosage form | |
MX354416B (es) | Formulaciones a base de nalbufina y sus usos. | |
WO2007092620A3 (en) | Stable formulations, and methods of their preparation and use | |
WO2004062577A3 (en) | Two or more enteric materials to regulate drug release | |
MY149623A (en) | Sprayable gel-type skin/mucosa-adhesive preparation and administration system using the preparation | |
IL195269A0 (en) | Pharmaceutical formulations for the sustained release of active ingredient(s), as well as their applications, especially therapeutic | |
FR2949062B1 (fr) | Nouvelles formulations pharmaceutiques contre le mesusage des medicaments | |
IL177243A0 (en) | Extended release coated minitablets of venlafaxine hydrochloride | |
TW200602090A (en) | Antibiotic-based pharmaceutical formulation in microcapsular form | |
WO2007144169A3 (en) | Entacapone-derivatives | |
WO2006060325A3 (en) | Coated drug delivery formulations | |
WO2009106824A3 (en) | Pharmaceutical formulations with a taste masking coating | |
BG108516A (en) | Pharmaceutical formulation | |
WO2012092486A3 (en) | Modified release benzimidazole formulations | |
WO2009028598A1 (ja) | 徐放性製剤及びその製造方法 | |
HK1120417A1 (en) | Stable nanoparticle formulations | |
ATE460934T1 (de) | Pharmazeutische zubereitungen von ciprofloxacin | |
GEP20115158B (en) | Use of ivabradine for obtaining medicaments intended for the treatment of endothelial dysfunction | |
GB0522474D0 (en) | A pharmaceutical formulation |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
HH | Correction or change in general | ||
FG | Grant or registration |